{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:44:44Z","timestamp":1790934284099,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.humpath.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T22:18:59Z","timestamp":1448921939000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["miR-31 and miR-17-5p levels change during transformation of follicular lymphoma"],"prefix":"10.1016","volume":"50","author":[{"given":"Mary Ann","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick D.","family":"Edmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McClintock-Treep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Eischen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.11.011_bb0005","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2015.11.011_bb0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcp\/103.4.472","article-title":"Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma","volume":"103","author":"Horsman","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9440(10)63313-5","article-title":"Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component","volume":"165","author":"Katzenberger","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0020","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1582-4934.2008.00628.x","article-title":"Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma","volume":"13","author":"Lawrie","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2015.11.011_bb0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.11.011_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2015.11.011_bb0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms","volume":"136","author":"Davies","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/modpathol.3800100","article-title":"Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma","volume":"17","author":"Lin","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2015.11.011_bb0060","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1073\/pnas.83.9.2984","article-title":"Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma","volume":"83","author":"Pelicci","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2015.11.011_bb0065","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/emboj.2013.178","article-title":"MicroRNA-17~92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways","volume":"32","author":"Jin","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2015.11.011_bb0070","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1315365110","article-title":"B-cell malignancies in microRNA Emu-miR-17~92 transgenic mice","volume":"110","author":"Sandhu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2015.11.011_bb0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/gcc.22107","article-title":"The diverse role of miR-31 in regulating cancer associated phenotypes","volume":"52","author":"Laurila","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2015.11.011_bb0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","article-title":"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas","volume":"142","author":"Roehle","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0085","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/0008-5472.CAN-09-4736","article-title":"MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival","volume":"70","author":"Arrate","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2015.11.011_bb0090","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/jid.2013.461","article-title":"miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides\/cutaneous T-cell lymphoma","volume":"134","author":"McGirt","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/gcc.20893","article-title":"Molecular characterization of 9p21 deletions shows a minimal common deleted region removing CDKN2A exon 1 and CDKN2B exon 2 in diffuse large B-cell lymphomas","volume":"50","author":"Guney","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2015.11.011_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MO:18:1:15","article-title":"Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma","volume":"18","author":"Llanos","year":"2001","journal-title":"Med Oncol"},{"key":"10.1016\/j.humpath.2015.11.011_bb0110","first-page":"457","article-title":"MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications","volume":"1846","author":"Sewastianik","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2015.11.011_bb0115","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.11.011_bb0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc\u2013regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2015.11.011_bb0125","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1073\/pnas.88.11.5006","article-title":"Genetic basis for p53 overexpression in human breast cancer","volume":"88","author":"Davidoff","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2015.11.011_bb0130","first-page":"131","article-title":"The genetics of the E2F family of transcription factors: shared functions and unique roles","volume":"2002","author":"DeGregori","year":"1602","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2015.11.011_bb0135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrg1879","article-title":"The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism","volume":"7","author":"Engelman","year":"2006","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.humpath.2015.11.011_bb0140","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/cbin.10139","article-title":"Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21","volume":"37","author":"Shen","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.humpath.2015.11.011_bb0145","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1158\/1541-7786.MCR-07-0262","article-title":"Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death","volume":"6","author":"Elis","year":"2008","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.humpath.2015.11.011_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-11-5","article-title":"miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer","volume":"11","author":"Augoff","year":"2012","journal-title":"Mol Cancer"},{"key":"10.1016\/j.humpath.2015.11.011_bb0155","doi-asserted-by":"crossref","first-page":"e54398","DOI":"10.1371\/journal.pone.0054398","article-title":"miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer","volume":"8","author":"Vrba","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.11.011_bb0160","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1158\/0008-5472.CAN-12-2968","article-title":"Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression","volume":"73","author":"Lin","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2015.11.011_bb0165","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.molcel.2014.01.029","article-title":"The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31","volume":"53","author":"Vire","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.humpath.2015.11.011_bb0170","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","article-title":"Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters","volume":"132","author":"Ventura","year":"2008","journal-title":"Cell"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715004815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715004815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T04:50:59Z","timestamp":1537159859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715004815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":34,"alternative-id":["S0046817715004815"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.11.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-31 and miR-17-5p levels change during transformation of follicular lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}